Total Reports
7
Low report volume
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for Deer (other) (Deer) in the FDA Center for Veterinary Medicine openFDA extract. Browse deer breeds, reactions, and outcomes below.
By recorded gender -- every report on file for Deer (other), no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Deer (other) ranks #460 of 510 by total reports (7). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Deer (other) has 7 reports now versus 7 in that prior snapshot: 0 the same number of (0.0%).
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Deer (other) changesTotal Reports
7
Low report volume
Deaths Reported
5
of 7 reports
Death-coded share of reports
71.4%
71.4% death-coded
Avg Age at Report
1.3 yr
88.5 kg avg weight
71.4% of 7 deer (other) reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2017 | 1 | |
| 2021 | 1 | |
| 2023 | 1 | |
| 2024 | 2 | |
| 2025 | 2 | |
Signature read: 7 reports place Deer (other) in the lower third of breed filing volume (#463 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Deer (other) sits at #463 of 510 by report volume among all breeds and #1 of 2 among deer breeds, with 7 reports and 5 (71.4%) death-coded. Mean age at report: 1.3 years, average weight 88.5 kg (195.1 lbs).
Top reported signs: Death (3), Haemorrhage NOS (1), Pulmonary disorder NOS (1). Most-referenced drug: Monensin Sodium (2 reports), followed by Tolazoline Hydrochloride (1) and Tiletamine Hydrochloride + Zolazepam Hydrochloride (1).
Outcome coding on 8 status-recorded reports is dominated by Died (50.0%). Annual submissions ranged 1-2,025 across 5 years on file.
Sparse-volume peer sets for Deer (other) drawn from openFDA outside the Deer family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds by reported average weight (88.5 kg here).
What to do with this deer
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →